SJM
36
7
CPB
44
4
EOG
49
4
IFF
59
5
DVN
25
7
D
37
2
SO
73
3
HP
37
3
KR
40
-10
EMR
50
2
APA
21
-4
PEG
46
5
AIG
53
2
MCHP
49
-3
CL
77
2
CRM
54
-3
UPS
48
2
VIX
33
3
HSY
53
8
EMN
69
6
SJM
36
7
CPB
44
4
EOG
49
4
IFF
59
5
DVN
25
7
D
37
2
SO
73
3
HP
37
3
KR
40
-10
EMR
50
2
APA
21
-4
PEG
46
5
AIG
53
2
MCHP
49
-3
CL
77
2
CRM
54
-3
UPS
48
2
VIX
33
3
HSY
53
8
EMN
69
6
Financhill
Back

Seadrill Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

SDRL
Seadrill

Last Price:
48.86
Seasonality Move:
13.74%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
49
Seadrill (SDRL) is a Sell

Is Seadrill a Buy, Sell or Hold?

  • The current Seadrill [SDRL] share price is $48.76. The Score for SDRL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SDRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SDRL Stock Price Chart

What is Seadrill's stock price today?

  • The Seadrill share price today is $48.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SDRL is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

SDRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 45.02 Sell
Chaikin Money Flow: -260345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.86 - 51.66) Sell
Bollinger Bands (100): (45.06 - 51.86) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

SDRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.05 Sell
20-day SMA: 49.92 Sell
50-day SMA: 50.31 Sell
200-day SMA: 46.08 Buy
8-day EMA: 49.06 Sell
20-day EMA: 49.69 Sell
50-day EMA: 49.84 Sell
200-day EMA: 46.48 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Seadrill Earnings Growth & SDRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.51 per share, an increase next quarter of $1.01 per share, a decrease this year of $1.56 per share, and an increase next year of $2.85 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Seadrill Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):